Zephyrnet Logo

Tag: insightec

Insightec’s groundbreaking transcranial MR-Guided focused ultrasound (MRgFUS) approved for additional reimbursement for essential tremor in Germany – OurCrowd Blog

Germany is latest – and largest – European country to enable substantial access to focused ultrasound, offering new hope of relief for those suffering...

Top News

[Insightec in U.S. News] Noninvasive ultrasound brain treatment might help slow Parkinson’s

THURSDAY, Feb. 23, 2023 (HealthDay News) — A noninvasive treatment that heats specific areas of brain tissue may ease movement symptoms in some people...

[Insightec in FAU] FAU, Delray Medical Center, Insightec team up on groundbreaking study

Delray Medical Center is the first hospital in Florida to treat an Alzheimer’s disease patient using non-invasive focused ultrasound technology as part of a...

[Insightec in PR Newswire] Insightec announces positive coverage decision by cigna for focused ultrasound to treat essential tremor

HAIFA, Israel & MIAMI, Jan. 31, 2023 /PRNewswire/ — Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care, today...

[Insightec in CNN] A sound you can’t hear but may one day change your life

CNN—Undergoing clinical trials around the world is a brain surgery that doesn’t need an incision or produce any blood yet drastically improves the lives...

[Insightec in PR Newswire] Insightec to present at the 41st Annual J.P. Morgan Healthcare Conference

HAIFA, Israel & MIAMI, Jan. 4, 2023 /PRNewswire/ — Insightec, an incisionless platform medical device company dedicated to using acoustic energy to transform patient...

[Insightec in PR Newswire] Insightec announces positive coverage decision by anthem for MR-guided focused ultrasound to treat essential tremor

HAIFA, Israel – MIAMI, Dec. 22, 2022 /PRNewswire/ — Insightec®, a global healthcare company dedicated to using acoustic energy to transform patient care, announced...

[Insightec in PR Newswire] Insightec receives FDA approval to treat essential tremor patients’ second side, expanding total available market in United States

HAIFA, Israel & MIAMI, Dec. 20, 2022 /PRNewswire/ — Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care, today...

[Insightec in Shine] Non-invasive brain disease treatment center established in Shanghai

A center for non-invasive brain disease treatment was established at Shanghai International Medical Center on Monday, offering innovative treatment for patients with nervous system...

[Insightec in PR Newswire] Insightec receives FDA IDE approval for prostate cancer comparative study using high intensity focused ultrasound technology

HAIFA, Israel and MIAMI, June 30, 2022 /PRNewswire/ — Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care, today...

[Insightec in Haaretz] Focused ultrasound is replacing the surgeon’s scalpel

The Israeli start-up Insightec has developed a revolutionary technology for non-invasive treatment of human tissue, leading to significantly reduced damage, bleeding, infections and hospitalization Read...

Newsletter: Talking photos + Personalized sneakers

Top investment opportunities Startup of the Week: Kicksnation: Free personalized sneaker shopper D-ID launches talking photos tech with MyHeritage 3D printing gets bigger, faster, tastier Taranis drones weed out crop pests and diseases Payoneer picks ThetaRay to secure global transactions FDA approves two Insightec acoustic energy cancer treatments American Airlines joins Freightos’ WebCargo US Energy […]

The post Newsletter: Talking photos + Personalized sneakers appeared first on OurCrowd Blog.

[Insightec in PR Newswire] Insightec receives FDA IDE approval and “Breakthrough” designation for NSCLC Brain Mets Study and IDE approval for Liquid Biopsy Study

HAIFA, Israel & MIAMI, March 9, 2022 /CNW/ — Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care, today announced that it has received FDA approval of two pivotal investigational device exemptions (IDE) for its Exablate Neuro system – one for primary non-small cell lung cancer (NSCLC) that has metastasized […]

The post [Insightec in PR Newswire] Insightec receives FDA IDE approval and “Breakthrough” designation for NSCLC Brain Mets Study and IDE approval for Liquid Biopsy Study appeared first on OurCrowd Blog.

Latest Intelligence

spot_img
spot_img